BioCentury
ARTICLE | Financial News

Truffle Capital raises $102M toward life science and medtech fund

January 12, 2018 4:39 PM UTC

Life sciences and information technology VC Truffle Capital raised $102 million toward its planned $240 million Truffle BioMedTech fund in an initial closing. The Paris-based firm said it remains on track to raise the remaining funds this year. New investors Guerbet S.A. (Euronext:GBT), Fonds de réserve pour les retraites (FFR) and CIPAV participated.

The fund will create and invest in 12 French start-ups founded on technology from universities in North American and Europe...

BCIQ Company Profiles

Abivax S.A.

Pharnext S.A.